Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACULAR for Retinopathy of Prematurity
NCT00634972Phase 4Terminated
- Sponsor
- University of South Alabama
- Start
- Nov 2005
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ketorolac in retinopathy of prematurity (ROP), sponsored by University of South Alabama. Started Nov 2005; status: terminated.
02
Drugs
ketorolac
03
Conditions
retinopathy of prematurity (ROP)
Beyond the preview
Go deeper on NCT00634972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00634972.